Breakthrough brings potential glioblastoma drug into focus
Glioblastoma, the most common cancerous brain tumor in adults, is an aggressive disease—patients survive an average of just 15 months once they are diagnosed. Despite more than two decades of research on the causes and ...
Sep 26, 2022
1
59